A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.

NCT01135498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: eloxatin
DRUG: capecitabine [Xeloda]
DRUG: erlotinib [Tarceva]

Sponsor

Hoffmann-La Roche